286 related articles for article (PubMed ID: 1531910)
1. Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease.
Harris GJ; Pearlson GD; Peyser CE; Aylward EH; Roberts J; Barta PE; Chase GA; Folstein SE
Ann Neurol; 1992 Jan; 31(1):69-75. PubMed ID: 1531910
[TBL] [Abstract][Full Text] [Related]
2. Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study.
Peinemann A; Schuller S; Pohl C; Jahn T; Weindl A; Kassubek J
J Neurol Sci; 2005 Dec; 239(1):11-9. PubMed ID: 16185716
[TBL] [Abstract][Full Text] [Related]
3. Elevated brain iron is independent from atrophy in Huntington's Disease.
Dumas EM; Versluis MJ; van den Bogaard SJ; van Osch MJ; Hart EP; van Roon-Mom WM; van Buchem MA; Webb AG; van der Grond J; Roos RA;
Neuroimage; 2012 Jul; 61(3):558-64. PubMed ID: 22480728
[TBL] [Abstract][Full Text] [Related]
4. Shape analysis of subcortical nuclei in Huntington's disease, global versus local atrophy--results from the TRACK-HD study.
van den Bogaard SJ; Dumas EM; Ferrarini L; Milles J; van Buchem MA; van der Grond J; Roos RA
J Neurol Sci; 2011 Aug; 307(1-2):60-8. PubMed ID: 21624624
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy.
Schulz JB; Skalej M; Wedekind D; Luft AR; Abele M; Voigt K; Dichgans J; Klockgether T
Ann Neurol; 1999 Jan; 45(1):65-74. PubMed ID: 9894879
[TBL] [Abstract][Full Text] [Related]
6. Caudate nucleus atrophy in Huntington's disease and its relationship with clinical and genetic parameters.
Roth J; Klempìi J; Jech R; Zidovská J; Uhrová T; Doubek P; Ulmanová O; Brozová H; Volfová M; Serranová T; Ruzicka E
Funct Neurol; 2005; 20(3):127-30. PubMed ID: 16324236
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging-based volumetric analysis of basal ganglia nuclei and substantia nigra in patients with Parkinson's disease.
Geng DY; Li YX; Zee CS
Neurosurgery; 2006 Feb; 58(2):256-62; discussion 256-62. PubMed ID: 16462479
[TBL] [Abstract][Full Text] [Related]
8. Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study.
Douaud G; Gaura V; Ribeiro MJ; Lethimonnier F; Maroy R; Verny C; Krystkowiak P; Damier P; Bachoud-Levi AC; Hantraye P; Remy P
Neuroimage; 2006 Oct; 32(4):1562-75. PubMed ID: 16875847
[TBL] [Abstract][Full Text] [Related]
9. MR relaxometry in Huntington's disease: correlation between imaging, genetic and clinical parameters.
Vymazal J; Klempír J; Jech R; Zidovská J; Syka M; Růzicka E; Roth J
J Neurol Sci; 2007 Dec; 263(1-2):20-5. PubMed ID: 17585943
[TBL] [Abstract][Full Text] [Related]
10. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease.
Bartzokis G; Tishler TA
Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):821-33. PubMed ID: 10875443
[TBL] [Abstract][Full Text] [Related]
11. White matter integrity in premanifest and early Huntington's disease is related to caudate loss and disease progression.
Novak MJ; Seunarine KK; Gibbard CR; Hobbs NZ; Scahill RI; Clark CA; Tabrizi SJ
Cortex; 2014 Mar; 52():98-112. PubMed ID: 24405816
[TBL] [Abstract][Full Text] [Related]
12. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
Huot P; Lévesque M; Parent A
Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
[TBL] [Abstract][Full Text] [Related]
13. Functional MRI study of a serial reaction time task in Huntington's disease.
Kim JS; Reading SA; Brashers-Krug T; Calhoun VD; Ross CA; Pearlson GD
Psychiatry Res; 2004 May; 131(1):23-30. PubMed ID: 15246452
[TBL] [Abstract][Full Text] [Related]
14. Bicaudate index on magnetic resonance imaging: effects of normal aging.
Doraiswamy PM; Patterson L; Na C; Husain MM; Boyko O; McDonald WM; Krishnan KR
J Geriatr Psychiatry Neurol; 1994; 7(1):13-7. PubMed ID: 8192824
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging in Huntington's disease.
Sethi KD
Mov Disord; 1991; 6(2):186. PubMed ID: 1829138
[No Abstract] [Full Text] [Related]
16. Regional specificity of brain atrophy in Huntington's disease.
Halliday GM; McRitchie DA; Macdonald V; Double KL; Trent RJ; McCusker E
Exp Neurol; 1998 Dec; 154(2):663-72. PubMed ID: 9878201
[TBL] [Abstract][Full Text] [Related]
17. Images in clinical medicine. Huntington's chorea.
Malekpour M; Esfandbod M
N Engl J Med; 2010 Oct; 363(15):e24. PubMed ID: 20925538
[No Abstract] [Full Text] [Related]
18. Single photon emission computed tomographic blood flow and magnetic resonance volume imaging of basal ganglia in Huntington's disease.
Harris GJ; Aylward EH; Peyser CE; Pearlson GD; Brandt J; Roberts-Twillie JV; Barta PE; Folstein SE
Arch Neurol; 1996 Apr; 53(4):316-24. PubMed ID: 8929153
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-weighted imaging in Huntington's disease.
Seppi K; Schocke MF; Mair KJ; Esterhammer R; Weirich-Schwaiger H; Utermann B; Egger K; Brenneis C; Granata R; Boesch S; Poewe W; Wenning GK
Mov Disord; 2006 Jul; 21(7):1043-7. PubMed ID: 16570300
[TBL] [Abstract][Full Text] [Related]
20. Multimodal imaging biomarkers in premanifest and early Huntington's disease: 30-month IMAGE-HD data.
D JF; Stout JC; Poudel G; Churchyard A; Chua P; Egan GF; Georgiou-Karistianis N
Br J Psychiatry; 2016 Jun; 208(6):571-8. PubMed ID: 26678864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
